Biotech Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer January 13, 2025
Biotech Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program January 13, 2025
Biotech Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb). January 13, 2025
Biotech Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease Portfolio January 13, 2025
Biotech JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma January 13, 2025
Biotech Alchemab Therapeutics enters into collaboration with Lilly to discover, research and develop novel therapies for ALS January 9, 2025
Biotech Ventris Medical Receives 510(k) Clearance for Innovative Backpack® Bone Graft Containment System January 9, 2025
Biotech Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics January 8, 2025
Biotech Vesper Bio initiates Phase Ib/IIa proof of concept study of VES001 in asymptomatic patients with gene mutations that cause frontotemporal dementia (FTD) January 7, 2025